Cargando…
Cognitive impairment indicator for the neuropsychological test batteries in the Canadian Longitudinal Study on Aging: definition and evidence for validity
BACKGROUND: Prevalence of overall cognitive impairment based on each participant’s performance across a neuropsychological battery is challenging; consequently, we define and validate a dichotomous cognitive impairment/no cognitive indicator (CII) using a neuropsychological battery administered in a...
Autores principales: | , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10552318/ https://www.ncbi.nlm.nih.gov/pubmed/37798677 http://dx.doi.org/10.1186/s13195-023-01317-3 |
_version_ | 1785115936388284416 |
---|---|
author | O’Connell, Megan E. Kadlec, Helena Griffith, Lauren E. Wolfson, Christina Maimon, Geva Taler, Vanessa Kirkland, Susan Raina, Parminder |
author_facet | O’Connell, Megan E. Kadlec, Helena Griffith, Lauren E. Wolfson, Christina Maimon, Geva Taler, Vanessa Kirkland, Susan Raina, Parminder |
author_sort | O’Connell, Megan E. |
collection | PubMed |
description | BACKGROUND: Prevalence of overall cognitive impairment based on each participant’s performance across a neuropsychological battery is challenging; consequently, we define and validate a dichotomous cognitive impairment/no cognitive indicator (CII) using a neuropsychological battery administered in a population-based study. This CII approximates the clinical practice of interpretation across a neuropsychological battery and can be applied to any neuropsychological dataset. METHODS: Using data from participants aged 45–85 in the Canadian Longitudinal Study on Aging receiving a telephone-administered neuropsychological battery (Tracking, N = 21,241) or a longer in-person battery (Comprehensive, N = 30,097), impairment was determined for each neuropsychological test based on comparison with normative data. We adjusted for the joint probability of abnormally low scores on multiple neuropsychological tests using baserates of low scores demonstrated in the normative samples and created a dichotomous CII (i.e., cognitive impairment vs no cognitive impairment). Convergent and discriminant validity of the CII were assessed with logistic regression analyses. RESULTS: Using the CII, the prevalence of cognitive impairment was 4.3% in the Tracking and 5.0% in the Comprehensive cohorts. The CII demonstrated strong convergent and discriminant validity. CONCLUSIONS: The approach for the CII is a feasible method to identify participants who demonstrate cognitive impairment on a battery of tests. These methods can be applied in other epidemiological studies that use neuropsychological batteries. |
format | Online Article Text |
id | pubmed-10552318 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-105523182023-10-06 Cognitive impairment indicator for the neuropsychological test batteries in the Canadian Longitudinal Study on Aging: definition and evidence for validity O’Connell, Megan E. Kadlec, Helena Griffith, Lauren E. Wolfson, Christina Maimon, Geva Taler, Vanessa Kirkland, Susan Raina, Parminder Alzheimers Res Ther Research BACKGROUND: Prevalence of overall cognitive impairment based on each participant’s performance across a neuropsychological battery is challenging; consequently, we define and validate a dichotomous cognitive impairment/no cognitive indicator (CII) using a neuropsychological battery administered in a population-based study. This CII approximates the clinical practice of interpretation across a neuropsychological battery and can be applied to any neuropsychological dataset. METHODS: Using data from participants aged 45–85 in the Canadian Longitudinal Study on Aging receiving a telephone-administered neuropsychological battery (Tracking, N = 21,241) or a longer in-person battery (Comprehensive, N = 30,097), impairment was determined for each neuropsychological test based on comparison with normative data. We adjusted for the joint probability of abnormally low scores on multiple neuropsychological tests using baserates of low scores demonstrated in the normative samples and created a dichotomous CII (i.e., cognitive impairment vs no cognitive impairment). Convergent and discriminant validity of the CII were assessed with logistic regression analyses. RESULTS: Using the CII, the prevalence of cognitive impairment was 4.3% in the Tracking and 5.0% in the Comprehensive cohorts. The CII demonstrated strong convergent and discriminant validity. CONCLUSIONS: The approach for the CII is a feasible method to identify participants who demonstrate cognitive impairment on a battery of tests. These methods can be applied in other epidemiological studies that use neuropsychological batteries. BioMed Central 2023-10-05 /pmc/articles/PMC10552318/ /pubmed/37798677 http://dx.doi.org/10.1186/s13195-023-01317-3 Text en © The Author(s) 2023 https://creativecommons.org/licenses/by/4.0/Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data. |
spellingShingle | Research O’Connell, Megan E. Kadlec, Helena Griffith, Lauren E. Wolfson, Christina Maimon, Geva Taler, Vanessa Kirkland, Susan Raina, Parminder Cognitive impairment indicator for the neuropsychological test batteries in the Canadian Longitudinal Study on Aging: definition and evidence for validity |
title | Cognitive impairment indicator for the neuropsychological test batteries in the Canadian Longitudinal Study on Aging: definition and evidence for validity |
title_full | Cognitive impairment indicator for the neuropsychological test batteries in the Canadian Longitudinal Study on Aging: definition and evidence for validity |
title_fullStr | Cognitive impairment indicator for the neuropsychological test batteries in the Canadian Longitudinal Study on Aging: definition and evidence for validity |
title_full_unstemmed | Cognitive impairment indicator for the neuropsychological test batteries in the Canadian Longitudinal Study on Aging: definition and evidence for validity |
title_short | Cognitive impairment indicator for the neuropsychological test batteries in the Canadian Longitudinal Study on Aging: definition and evidence for validity |
title_sort | cognitive impairment indicator for the neuropsychological test batteries in the canadian longitudinal study on aging: definition and evidence for validity |
topic | Research |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10552318/ https://www.ncbi.nlm.nih.gov/pubmed/37798677 http://dx.doi.org/10.1186/s13195-023-01317-3 |
work_keys_str_mv | AT oconnellmegane cognitiveimpairmentindicatorfortheneuropsychologicaltestbatteriesinthecanadianlongitudinalstudyonagingdefinitionandevidenceforvalidity AT kadlechelena cognitiveimpairmentindicatorfortheneuropsychologicaltestbatteriesinthecanadianlongitudinalstudyonagingdefinitionandevidenceforvalidity AT griffithlaurene cognitiveimpairmentindicatorfortheneuropsychologicaltestbatteriesinthecanadianlongitudinalstudyonagingdefinitionandevidenceforvalidity AT wolfsonchristina cognitiveimpairmentindicatorfortheneuropsychologicaltestbatteriesinthecanadianlongitudinalstudyonagingdefinitionandevidenceforvalidity AT maimongeva cognitiveimpairmentindicatorfortheneuropsychologicaltestbatteriesinthecanadianlongitudinalstudyonagingdefinitionandevidenceforvalidity AT talervanessa cognitiveimpairmentindicatorfortheneuropsychologicaltestbatteriesinthecanadianlongitudinalstudyonagingdefinitionandevidenceforvalidity AT kirklandsusan cognitiveimpairmentindicatorfortheneuropsychologicaltestbatteriesinthecanadianlongitudinalstudyonagingdefinitionandevidenceforvalidity AT rainaparminder cognitiveimpairmentindicatorfortheneuropsychologicaltestbatteriesinthecanadianlongitudinalstudyonagingdefinitionandevidenceforvalidity |